In vivostudies demonstrated that the combination of this nanomedicine with anti-PD-L1 significantly inhibited tumor growth (Figure 2B) and prolongedthe survival time of orthotopic pancreatic tumor-bearing mice (Figure 2C). This evidence concerns the gene CD274 and neoplasm.